ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $829,789 | +77.6% | 180,389 | +149.4% | 0.02% | +46.2% |
| Q2 2023 | $467,245 | -86.9% | 72,329 | -84.7% | 0.01% | -88.1% |
| Q1 2023 | $3,575,845 | +136.6% | 474,250 | +217.9% | 0.11% | +137.0% |
| Q4 2022 | $1,511,385 | -62.2% | 149,199 | -63.1% | 0.05% | -70.9% |
| Q3 2022 | $3,997,000 | +492.1% | 404,171 | +537.1% | 0.16% | +485.2% |
| Q2 2022 | $675,000 | +83.9% | 63,439 | +146.6% | 0.03% | +68.8% |
| Q4 2021 | $367,000 | – | 25,727 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |